FdaApplication
ANDA 209202
Identifiers
- fda_app_no: ANDA209202
Properties
| Property | Value |
|---|---|
| applicant_name | P AND L DEVELOPMENT LLC |
| application_type | ANDA |
| approval_date | 2019-03-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE;ORAL |
1 product